SLC5A3 and Alzheimer disease: A comparison of SMIT1 and SMIT2 expression between TgCRND8 mice and non-Tg littermate mice, at 2, 4 and 6 months of age, was used to determine the effects of AD-like amyloid pathology on transporter expression.